295 related articles for article (PubMed ID: 21835884)
1. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.
Giralt A; Saavedra A; Carretón O; Xifró X; Alberch J; Pérez-Navarro E
Hum Mol Genet; 2011 Nov; 20(21):4232-47. PubMed ID: 21835884
[TBL] [Abstract][Full Text] [Related]
2. PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model.
Giralt A; Saavedra A; Carretón O; Arumí H; Tyebji S; Alberch J; Pérez-Navarro E
Hippocampus; 2013 Aug; 23(8):684-95. PubMed ID: 23576401
[TBL] [Abstract][Full Text] [Related]
3. Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.
Tyebji S; Saavedra A; Canas PM; Pliassova A; Delgado-García JM; Alberch J; Cunha RA; Gruart A; Pérez-Navarro E
Neurobiol Dis; 2015 Feb; 74():41-57. PubMed ID: 25449908
[TBL] [Abstract][Full Text] [Related]
4. Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement.
Hosseini-Sharifabad A; Ghahremani MH; Sabzevari O; Naghdi N; Abdollahi M; Beyer C; Bollen E; Prickaerts J; Roghani A; Sharifzadeh M
Pharmacol Biochem Behav; 2012 May; 101(3):311-9. PubMed ID: 22306745
[TBL] [Abstract][Full Text] [Related]
5. Changes in the expression of extracellular regulated kinase (ERK 1/2) in the R6/2 mouse model of Huntington's disease after phosphodiesterase IV inhibition.
Fusco FR; Anzilotti S; Giampà C; Dato C; Laurenti D; Leuti A; Colucci D'Amato L; Perrone L; Bernardi G; Melone MA
Neurobiol Dis; 2012 Apr; 46(1):225-33. PubMed ID: 22311347
[TBL] [Abstract][Full Text] [Related]
6. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
[TBL] [Abstract][Full Text] [Related]
8. Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK.
Li X; Vadrevu S; Dunlop A; Day J; Advant N; Troeger J; Klussmann E; Jaffrey E; Hay RT; Adams DR; Houslay MD; Baillie GS
Biochem J; 2010 Apr; 428(1):55-65. PubMed ID: 20196770
[TBL] [Abstract][Full Text] [Related]
9. "Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease.
Wood NI; Glynn D; Morton AJ
Neurobiol Dis; 2011 Jun; 42(3):427-37. PubMed ID: 21324361
[TBL] [Abstract][Full Text] [Related]
10. Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.
Giralt A; Puigdellívol M; Carretón O; Paoletti P; Valero J; Parra-Damas A; Saura CA; Alberch J; Ginés S
Hum Mol Genet; 2012 Mar; 21(6):1203-16. PubMed ID: 22116937
[TBL] [Abstract][Full Text] [Related]
11. Behavioural state differentially engages septohippocampal cholinergic and GABAergic neurons in R6/1 Huntington's disease mice.
Ransome MI; Hannan AJ
Neurobiol Learn Mem; 2012 Feb; 97(2):261-70. PubMed ID: 22261461
[TBL] [Abstract][Full Text] [Related]
12. Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.
Moriguchi S; Yamamoto Y; Ikuno T; Fukunaga K
J Neurochem; 2011 Jun; 117(5):879-91. PubMed ID: 21434925
[TBL] [Abstract][Full Text] [Related]
13. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice.
Hebb AL; Robertson HA; Denovan-Wright EM
Eur Neuropsychopharmacol; 2008 May; 18(5):339-63. PubMed ID: 17913473
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity.
Anglada-Huguet M; Vidal-Sancho L; Giralt A; García-Díaz Barriga G; Xifró X; Alberch J
Neurobiol Dis; 2016 Nov; 95():22-34. PubMed ID: 26369879
[TBL] [Abstract][Full Text] [Related]
16. Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat.
Lebel M; Chagniel L; Bureau G; Cyr M
Neurobiol Dis; 2010 Apr; 38(1):59-67. PubMed ID: 20060905
[TBL] [Abstract][Full Text] [Related]
17. 4'-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade.
Al Rahim M; Nakajima A; Saigusa D; Tetsu N; Maruyama Y; Shibuya M; Yamakoshi H; Tomioka Y; Iwabuchi Y; Ohizumi Y; Yamakuni T
Biochemistry; 2009 Aug; 48(32):7713-21. PubMed ID: 19601643
[TBL] [Abstract][Full Text] [Related]
18. NMDA receptor activation results in PKA- and ERK-dependent Mnk1 activation and increased eIF4E phosphorylation in hippocampal area CA1.
Banko JL; Hou L; Klann E
J Neurochem; 2004 Oct; 91(2):462-70. PubMed ID: 15447679
[TBL] [Abstract][Full Text] [Related]
19. Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease.
Saavedra A; Giralt A; Arumí H; Alberch J; Pérez-Navarro E
PLoS One; 2013; 8(9):e73664. PubMed ID: 24040016
[TBL] [Abstract][Full Text] [Related]
20. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
Nagakura A; Niimura M; Takeo S
Br J Pharmacol; 2002 Apr; 135(7):1783-93. PubMed ID: 11934820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
